FOLD
Amicus Therapeutics Inc
NASDAQ: FOLD · HEALTHCARE · BIOTECHNOLOGY
$14.49
+0.00% today
Updated 2026-04-27
Market cap
$4.55B
P/E ratio
—
P/S ratio
7.17x
EPS (TTM)
$-0.09
Dividend yield
—
52W range
$6 – $15
Volume
3.5M
Amicus Therapeutics Inc (FOLD) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$14.49
12-Month target
—
2030 Target
—
Intrinsic (DCF)
—
Financial forecast
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $0.3B | $0.3B | $0.4B | $0.5B | $0.6B |
| EPS | — | — | — | — | — |
CAGR applied: — (capped 20%) · P/E: 25.00x (capped 25x) · Margin: -4.28%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.